Perea F - Search Results

1

Founding mutations explains hotspots of polycystic kidney disease in Southern Spain.

García Rabaneda C, Perea F, Bellido Díaz ML, Morales García AI, Martínez Atienza M, Sousa Silva L, González MÁG, Ruiz-Cabello F, Esteban de la Rosa RJ. García Rabaneda C, et al. Among authors: perea f. Clin Kidney J. 2020 Dec 10;14(7):1845-1847. doi: 10.1093/ckj/sfaa261. eCollection 2021 Jul. Clin Kidney J. 2020. PMID: 34221391 Free PMC article.

2

Erratum to: Founding mutations explains hotspots of polycystic kidney disease in Southern Spain.

García Rabaneda C, Perea F, Bellido Díaz ML, Morales García AI, Martínez Atienza M, Sousa Silva L, González MÁG, Ruiz-Cabello F, Esteban de la Rosa RJ. García Rabaneda C, et al. Among authors: perea f. Clin Kidney J. 2021 Sep 16;14(11):2451. doi: 10.1093/ckj/sfab141. eCollection 2021 Nov. Clin Kidney J. 2021. PMID: 34754444 Free PMC article.

3

Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in Cancer.

Garrido MA, Perea F, Vilchez JR, Rodríguez T, Anderson P, Garrido F, Ruiz-Cabello F, Aptsiauri N. Garrido MA, et al. Among authors: perea f. Cancers (Basel). 2021 Oct 9;13(20):5046. doi: 10.3390/cancers13205046. Cancers (Basel). 2021. PMID: 34680201 Free PMC article.

4

The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.

Perea F, Bernal M, Sánchez-Palencia A, Carretero J, Torres C, Bayarri C, Gómez-Morales M, Garrido F, Ruiz-Cabello F. Perea F, et al. Int J Cancer. 2017 Feb 15;140(4):888-899. doi: 10.1002/ijc.30489. Epub 2016 Nov 7. Int J Cancer. 2017. PMID: 27785783 Free article.

5

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape.

Perea F, Sánchez-Palencia A, Gómez-Morales M, Bernal M, Concha Á, García MM, González-Ramírez AR, Kerick M, Martin J, Garrido F, Ruiz-Cabello F, Aptsiauri N. Perea F, et al. Oncotarget. 2017 Dec 19;9(3):4120-4133. doi: 10.18632/oncotarget.23469. eCollection 2018 Jan 9. Oncotarget. 2017. PMID: 29423109 Free PMC article.

6

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture.

Garrido F, Perea F, Bernal M, Sánchez-Palencia A, Aptsiauri N, Ruiz-Cabello F. Garrido F, et al. Among authors: perea f. Vaccines (Basel). 2017 Feb 27;5(1):7. doi: 10.3390/vaccines5010007. Vaccines (Basel). 2017. PMID: 28264447 Free PMC article. Review.

7

A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer.

Flores-Martín JF, Perea F, Exposito-Ruiz M, Carretero FJ, Rodriguez T, Villamediana M, Ruiz-Cabello F, Garrido F, Cózar-Olmo JM, Aptsiauri N. Flores-Martín JF, et al. Among authors: perea f. Ann Surg Oncol. 2019 Aug;26(8):2631-2639. doi: 10.1245/s10434-019-07371-2. Epub 2019 Apr 22. Ann Surg Oncol. 2019. PMID: 31011905

8

Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.

Gil-Julio H, Perea F, Rodriguez-Nicolas A, Cozar JM, González-Ramirez AR, Concha A, Garrido F, Aptsiauri N, Ruiz-Cabello F. Gil-Julio H, et al. Among authors: perea f. Int J Mol Sci. 2021 Jul 6;22(14):7248. doi: 10.3390/ijms22147248. Int J Mol Sci. 2021. PMID: 34298868 Free PMC article.

9

Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.

Diaz R, Orlandini A, Castellana N, Caccavo A, Corral P, Corral G, Chacón C, Lamelas P, Botto F, Díaz ML, Domínguez JM, Pascual A, Rovito C, Galatte A, Scarafia F, Sued O, Gutierrez O, Jolly SS, Miró JM, Eikelboom J, Loeb M, Maggioni AP, Bhatt DL, Yusuf S; ECLA PHRI COLCOVID Trial Investigators. Diaz R, et al. JAMA Netw Open. 2021 Dec 1;4(12):e2141328. doi: 10.1001/jamanetworkopen.2021.41328. JAMA Netw Open. 2021. PMID: 34964849 Free PMC article. Clinical Trial.

10

Hypotension prediction index guided goal-directed therapy to reduce postoperative acute kidney injury during major abdominal surgery: study protocol for a multicenter randomized controlled clinical trial.

Ripollés-Melchor J, Carrasco-Sánchez L, Tomé-Roca JL, Aldecoa C, Zorrilla-Vaca A, Lorente-Olazábal JV, Colomina MJ, Pérez A, Jiménez-López JI, Navarro-Pérez R, Abad-Gurumeta A, Monge-García MI; HYT Study Group. Ripollés-Melchor J, et al. Trials. 2024 Apr 29;25(1):288. doi: 10.1186/s13063-024-08113-w. Trials. 2024. PMID: 38685032 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page